Zhejiang AngLiKang Pharmaceutical CO.,LTD.

SZSE:002940 Stock Report

Market Cap: CN¥2.6b

Zhejiang AngLiKang PharmaceuticalLTD Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Guo Zheng

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure6.4yrs

Recent management updates

Recent updates

CEO

Guo Zheng (51 yo)

2yrs

Tenure

Mr. Guo Gang Zheng serves as GM & Director of Zhejiang AngLiKang Pharmaceutical CO.,LTD.

Board Members

NamePositionTenureCompensationOwnership
Nan Ping Fang
Board Secretary & Chairman of the Board10.1yrsCN¥802.30kno data
Guo Zheng
GM & Director1.9yrsno datano data
Huihao Lu
Deputy General Manager & Vice Chairman10.1yrsCN¥602.70k3.63%
CN¥ 95.6m
Xiufang Zhao
Independent Director4yrsCN¥100.00kno data
Xiaoyun Pan
Non-Employee Supervisor10.1yrsno data0.32%
CN¥ 8.4m
Zhe Hua Wu
Non-Independent Director10.1yrsCN¥100.00kno data
Hong Yuan
Independent Director6.4yrsCN¥100.00kno data
Weimin Mo
Independent Director4yrsCN¥100.00kno data
Ling Li
Non-Employee Supervisor4yrsno datano data

6.4yrs

Average Tenure

55yo

Average Age

Experienced Board: 002940's board of directors are considered experienced (6.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 09:51
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhejiang AngLiKang Pharmaceutical CO.,LTD. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution